George Demetri, M. Charles Forscher, M. Forscher limited his practice to the study and treatment of sarcomas and has more than twenty years of experience in the field. His referral base is nationwide. Seth M. Pollack, MD Dr. James Cancer Hospital and Richard J. Solove Research Institute. Anderson Cancer Center in In , Dr. Professor of Pathology at Stanford School of Medicine, and a renowned translational research scientist. His clinical Focus is in Anatomic Pathology and Sarcoma. William Tseng, M.
Blithedale Ave. Hit enter to search or ESC to close. Close Search. Medical Advisory Board. Our distinguished Medical Advisory Board provides strategic counsel on research breakthroughs and patient programs. Lee Moffitt Cancer Center.
During fellowship she began to specialize in sarcoma. He recently led the Phase II studies of Gleevec for GIST, as well as early studies of ET, the drug derived from sea squirts that has shown some success in treating some soft-tissue sarcomas. Demetri feels that his particular strength is new drug development based on rational scientific targets. His areas of expertise include chemotherapy for soft tissue and bone sarcomas as apart of a combined modality approach to sarcoma management.
Pollack worked previously at the University of Washington and Fred Hutchinson Cancer Research Center which is also where he did his medical oncology fellowship. Pollack has expertise in both sarcoma treatment and cancer immunotherapy. As a physician-scientist, he runs a translational research lab, developing new immunotherapies designed for patients with advanced sarcoma. He has developed and led multiple experimental immunotherapy trials for sarcoma patients.
Raphael Pollock, M. He received his MD degree from St. Louis University, St. Anderson Cancer Center, Houston, Texas. Upon completion of fellowship training in , Dr. Matt van de Rijn is the Sabine Kohler, M.
